Table 2.
Baseline characteristics of the enrolled population.
| Characteristics | Control (n=378) (%) | Ischemic stroke | P1 | P2 | P3 | ||
|---|---|---|---|---|---|---|---|
| LAA (n=268) (%) | SAO (n=128) (%) | Total (n=396) (%) | |||||
| Age, y (mean ±SD) | 63.31±4.84 | 63.88±4.8 | 63.68±4.35 | 63.74±4.49 | 0.542 | 0.255 | 0.200 |
| Gender (n, %) | 0.122 | 0.603 | 0.812 | ||||
| Male | 202 (53.4) | 150 (56) | 65 (50.8) | 215 (54.3) | |||
| Female | 176 (46.6) | 118 (44) | 63 (49.2) | 181 (45.7) | |||
| Smoking (n, %) | <0.001 | <0.001 | <0.001 | ||||
| No | 327 (86.5) | 192 (71.6) | 91 (71.1) | 283 (71.5) | |||
| Yes | 51 (13.5) | 76 (28.4) | 37 (28.9) | 113 (28.5) | |||
| Drinking (n, %) | 0.005 | <0.001 | <0.001 | ||||
| No | 323 (85.4) | 206 (76.9) | 89 (69.5) | 295 (74.5) | |||
| Yes | 55 (14.6) | 62 (23.1) | 39 (30.5) | 101 (25.5) | |||
| Hypertension (n, %) | <0.001 | <0.001 | <0.001 | ||||
| No | 328 (86.8) | 179 (66.8) | 83 (64.8) | 262 (66.2) | |||
| Yes | 50 (13.2) | 89 (33.2) | 45 (35.2) | 134 (33.8) | |||
| Diabetes (n, %) | <0.001 | <0.001 | <0.001 | ||||
| No | 349 (92.3) | 219 (81.7) | 104 (81.2) | 323 (81.6) | |||
| Yes | 29 (7.7) | 49 (18.3) | 24 (18.8) | 73 (18.4) | |||
| BMI | 24.25±1.07 | 24.1±1.12 | 24.26±1.07 | 24.21±1.09 | 0.946 | 0.160 | 0.550 |
| Lipedema (mean ±SD, mmol/L) | |||||||
| TG | 1.50±0.41 | 1.54±0.6 | 1.56±0.76 | 1.56±0.71 | 0.143 | 0.326 | 0.140 |
| TC | 4.49±0.88 | 4.69±0.99 | 4.41±0.89 | 4.60±0.97 | 0.008 | 0.389 | 0.104 |
| HDL-c | 1.24±0.18 | 1.03±0.23 | 1.1±0.25 | 1.08±0.24 | <0.001 | <0.001 | <0.001 |
| LDL-c | 2.88±0.34 | 3.01±0.46 | 2.93±0.4 | 2.98±0.44 | <0.001 | 0.199 | <0.001 |
P1 – LAA vs. Control; P2 – SAO vs. Control; P3 – total vs. control.